220 related articles for article (PubMed ID: 25466348)
21. Treating idiopathic pulmonary fibrosis: current opportunities and future challenges.
Richeldi L
Clin Respir J; 2012 Jul; 6(3):129-30. PubMed ID: 22697263
[No Abstract] [Full Text] [Related]
22. [Two drugs inhibit disease progression. Idiopathic lung fibrosis treatable for the first time].
Einecke D
MMW Fortschr Med; 2015 Feb; 157(2):24-5. PubMed ID: 25743506
[No Abstract] [Full Text] [Related]
23. Is pirfenidone effective for idiopathic pulmonary fibrosis?
Jeldres A; Labarca G
Medwave; 2017 Jan; 17(Suppl1):e6843. PubMed ID: 28112713
[TBL] [Abstract][Full Text] [Related]
24. Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.
Selvaggio AS; Noble PW
Annu Rev Med; 2016; 67():487-95. PubMed ID: 26565677
[TBL] [Abstract][Full Text] [Related]
25. Pirfenidone treatment of idiopathic pulmonary fibrosis.
Azuma A
Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
[TBL] [Abstract][Full Text] [Related]
26. FDA panel likes new treatment for idiopathic pulmonary fibrosis.
Morrow T
Manag Care; 2010 Apr; 19(4):53-4. PubMed ID: 20446566
[No Abstract] [Full Text] [Related]
27. Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?
Papiris SA; Kagouridis K; Kolilekas L; Triantafillidou C; Tsangaris I; Manali ED
Eur Respir J; 2012 Sep; 40(3):794-5. PubMed ID: 22941551
[No Abstract] [Full Text] [Related]
28. Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?
Inchingolo R; Condoluci C; Smargiassi A; Mastrobattista A; Boccabella C; Comes A; Golfi N; Richeldi L
Expert Opin Pharmacother; 2017 Oct; 18(15):1583-1594. PubMed ID: 28933616
[TBL] [Abstract][Full Text] [Related]
29. Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2.
Guler SA; Lindell KO; Swigris J; Ryerson CJ
Am J Respir Crit Care Med; 2021 Feb; 203(3):P7-P8. PubMed ID: 33522880
[No Abstract] [Full Text] [Related]
30. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
[No Abstract] [Full Text] [Related]
31. [Idiopathic pulmonary fibrosis: A new era, new challenges].
Cottin V
Rev Mal Respir; 2014 Sep; 31(7):583-6. PubMed ID: 25239578
[No Abstract] [Full Text] [Related]
32. [Idiopathic pulmonary fibrosis: treatment with pirfenidone].
Cano-Jiménez E
Arch Bronconeumol; 2012 Oct; 48 Suppl 2():16-8. PubMed ID: 23630972
[No Abstract] [Full Text] [Related]
33. Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.
Milger K; Kneidinger N; Neurohr C; Reichenberger F; Behr J
Eur Respir J; 2015 Oct; 46(4):1217-21. PubMed ID: 26341986
[No Abstract] [Full Text] [Related]
34. Pharmacological therapy does not contribute to survival in idiopathic pulmonary fibrosis.
Ishii H; Kushima H; Komiya K; Mizunoe S; Kadota J
Respiration; 2013; 86(1):86-7. PubMed ID: 23594834
[No Abstract] [Full Text] [Related]
35. Update in diffuse parenchymal lung disease, 2013.
Rosas IO; Kaminski N
Am J Respir Crit Care Med; 2015 Feb; 191(3):270-4. PubMed ID: 25635490
[TBL] [Abstract][Full Text] [Related]
36. Update in Interstitial Lung Disease 2014.
Belloli EA; Martinez FJ; Flaherty KR
Am J Respir Crit Care Med; 2015 Sep; 192(5):538-43. PubMed ID: 26561676
[No Abstract] [Full Text] [Related]
37. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
Poletti V; Ravaglia C; Tomassetti S
Expert Rev Respir Med; 2014 Oct; 8(5):539-45. PubMed ID: 25113033
[TBL] [Abstract][Full Text] [Related]
38. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
[TBL] [Abstract][Full Text] [Related]
39. Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis.
Fiddler CA; Simler N; Parfrey H; Miremadi A; Chilvers ER
Ann Am Thorac Soc; 2016 Aug; 13(8):1430-2. PubMed ID: 27509160
[No Abstract] [Full Text] [Related]
40. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis.
Hilberg O; Simonsen U; du Bois R; Bendstrup E
Clin Respir J; 2012 Jul; 6(3):131-43. PubMed ID: 22697264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
